Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.3B
262M shares
52-week range
$1.32 – $9.69
91% from low
Sector
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Exchange
NYSE
CS
Borrow rate
1.00%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M | $27.6M | $46.3M | $62.6M | $73.4M | $65.9M | $82.1M | $97.6M |
| Cost of revenue | $2.3M | $48.5M | $107.5M | $45.5M | $33.9M | $49.0M | $33.2M | $51.9M |
| Gross profit | −$729.0K | −$20.9M | −$61.2M | $17.1M | $39.5M | $16.9M | $48.8M | $45.7M |
| Gross margin | -47.8% | -75.8% | -132.4% | 27.3% | 53.8% | 25.6% | 59.5% | 46.9% |
| R&D | $35.0M | $48.9M | $49.7M | $74.5M | $88.0M | $55.6M | $37.8M | $36.3M |
| Operating income | −$53.1M | −$102.3M | −$161.6M | −$192.7M | −$193.0M | −$145.6M | −$74.4M | −$86.4M |
| EBITDA | −$52.7M | −$98.9M | −$160.2M | −$29.5M | −$162.7M | −$123.0M | −$60.9M | −$67.4M |
| Net income | −$50.8M | −$99.6M | −$162.7M | −$32.4M | −$168.7M | −$133.7M | −$72.5M | −$77.1M |
| Net margin | -3326.7% | -361.1% | -351.9% | -51.8% | -229.9% | -202.9% | -88.3% | -79.0% |
| EPS (diluted) | -9.63 | -16.45 | -26.87 | -0.19 | -0.84 | -0.65 | -0.34 | -0.31 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $119M | $-0.13 | $-0.13–$-0.12 | 2 |
| 2027 | $142M | $-0.09 | $-0.10–$-0.09 | 2 |
| 2028 | $175M | $0.03 | $0.01–$0.04 | 3 |
| 2029 | $433M | $0.66 | $0.64–$0.69 | 1 |
Forward consensus · source: Financial Modeling Prep
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
www.butterflynetwork.comNo one on the platform currently holds BFLY.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 505,753 | $1.0M |
| Execution date | Ratio |
|---|---|
| 2008-04-04 | 1-for-10reverse |
No one on the platform has traded BFLY yet.
| $2.2B |
| — |
| EVHEvolent Health, Inc. | $5.51 | +9.54% | $620M | — |
| FLGTFulgent Genetics, Inc. | $19.96 | +2.67% | $567M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 22.0× sales vs its 6.5× historical median P/S.
Fair value ≈ $2.62 · price $8.91 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$BFLY Tested the 9's four times and failed....g-bye 9's....next stop....Mid 8's......stay tuned for more downside... Stick a fork in it...Few Understand....😏
View on StockTwits ↗$BFLY Ultrasound had a big first half of 2026. Portable ultrasound is projected to lead in the US market for the first time. NASA used it to manage a medical emergency in orbit. Surgeons are bringing it into the OR. The FDA cleared a wave of AI-assisted tools. And MIT built augmented reality for a new use of ultrasound imaging. The technology is moving fast. Swipe to catch up.
View on StockTwits ↗@DrDonna $16B TAM. A portable, helium free, head MRI machine that you plug into a standard wall socket and costs 10-20% of what a traditional MRI machine costs. The images are just as good as a traditional MRI and the health care reimbursement is the same. Eventually there will be 2-5 in every hospital and one in every neurological office. There will be one at every NFL game and at every College and High School football game (ok, I made up that part, but it makes sense). They have been approved by the FDA here and the respective medical regulators in all of Europe and Asia. It will enable MRIs in rural parts of America and poor parts of the entire World. Most importantly, it is better than $BFLY. (I wish!)
View on StockTwits ↗$BFLY https://www.linkedin.com/pulse/medicine-has-data-problem-ai-enabled-imaging-fix-steve-cashman-czs1c/
View on StockTwits ↗$BFLY wow not only the most powerful diagnostic!!! Also a potential treatment!
View on StockTwits ↗$BFLY Regardless of the looooong, and I mean loooooong term prospects for BFLY, the stock has been hyped, period. When the $9 bid breaks again, the stock is headed a lot lower. Reminder: 30 days ago the stock was at 4.35. Zero justification for 100+% move up since then. Few Understand....😏
View on StockTwits ↗$BFLY 99% up in 1 month and you truckers still pump
View on StockTwits ↗$BFLY hanging on that cliff for the dive! Watch out
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.